Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. [electronic resource]
Producer: 20071018Description: 855-61; discussion 860-1 p. digitalISSN:- 0004-0010
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Axilla
- Breast Neoplasms -- drug therapy
- Carboplatin -- administration & dosage
- Contrast Media
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Gadolinium DTPA
- Humans
- Lymph Node Excision
- Lymph Nodes -- pathology
- Lymphatic Metastasis
- Magnetic Resonance Imaging -- methods
- Mastectomy
- Mastectomy, Segmental
- Middle Aged
- Neoadjuvant Therapy
- Paclitaxel -- administration & dosage
- Predictive Value of Tests
- Receptor, ErbB-2 -- analysis
- Retrospective Studies
- Sensitivity and Specificity
- Trastuzumab
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.